journal article·2025-01

Two‐Step Targeting‐Tunable Semiconducting Nanoswitches Amplify Mitochondrion Damage and PD‐L1 Blockade for Orthotopic Pancreatic Cancer Therapy

Zichao Li, Yijing Zhang, Meng Li, Jingchao Li

Advanced Functional Materials· Volume 35· Issue 3
Publisher page

Abstract

Abstract Pancreatic cancer is a malignancy tumor with luxuriant extracellular matrix (ECM) and highly immunosuppressive microenvironment and its therapy remains an enormous challenge. A two‐step targeting‐tunable strategy is proposed for orthotopic pancreatic cancer therapy via designing semiconducting nanoswitches (C/SPNT/αP) to amplify the mitochondrion damage and programmed death ligand 1 (PD‐L1) blockade. A mitochondrion‐targeting small nanoparticle (SPNT) consisting of mitochondrial targeting moiety triphenylphosphine (TPP) and semiconducting polymer is embedded with PD‐L1 antibody (αPD‐L1) into sono‐responsive collagen binding peptide (CBP)‐conjugated nanoliposomes to form C/SPNT/αP. In the first targeting step, C/SPNT/αP achieve ECM targeting to observably increase their enrichment into orthotopic pancreatic tumor sites because CBP can effectively bind to collagen in ECM. Upon ultrasound (US) irradiation, C/SPNT/αP mediate a sono‐responsive structural failure via sonodynamic effect for on‐demand releases of SPNT and αPD‐L1. In the second targeting step, SPNT target to mitochondria to induce mitochondrial damage under US irradiation for triggering amplified cell apoptosis and immunogenic cell death (ICD). Moreover, the released αPD‐L1 blocks the immunosuppressive pathway to further boost immunological effect. Such a novel therapeutic regimen can almost completely eradicate orthotopic pancreatic Panc02 and KPC tumors in mouse models. This study presents the first two‐step targeting‐tunable nanomedicine for treatments of deep‐seated orthotopic tumors.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced biosensing and bioanalysis techniques · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory for Modification of Chemical Fibers and Polymer Materials College of Biological Science and Medical Engineering Donghua University Shanghai 201620 China

Funding

Science and Technology Commission of Shanghai Municipality · National Natural Science Foundation of China

References (57)

Show source-provided references
1. 10.1038/s41571-020-0363-510.1038/s41571-020-0363-5 ↗
2. 10.1038/s41575-021-00470-010.1038/s41575-021-00470-0 ↗
3. 10.1038/s41571-019-0281-610.1038/s41571-019-0281-6 ↗
4. 10.1038/s41571-018-0112-110.1038/s41571-018-0112-1 ↗
5. 10.1038/nrclinonc.2013.6610.1038/nrclinonc.2013.66 ↗
6. 10.1038/s41467-022-31551-610.1038/s41467-022-31551-6 ↗
7. 10.1038/s41571-023-00746-110.1038/s41571-023-00746-1 ↗
8. 10.1021/jacs.0c0065010.1021/jacs.0c00650 ↗
9. 10.1021/acsnano.0c0886010.1021/acsnano.0c08860 ↗
10. 10.1002/adma.20230473510.1002/adma.202304735 ↗
11. 10.1038/s41573-018-0006-z10.1038/s41573-018-0006-z ↗
12. 10.1038/s41568-019-0186-910.1038/s41568-019-0186-9 ↗
13. 10.1038/s41577-019-0269-610.1038/s41577-019-0269-6 ↗
14. 10.1038/504S1a10.1038/504S1a ↗
15. 10.1038/s41578-019-0108-110.1038/s41578-019-0108-1 ↗
16. 10.1002/anie.20230520010.1002/anie.202305200 ↗
17. 10.1002/anie.20200838610.1002/anie.202008386 ↗
18. 10.1038/s41590-020-0761-y10.1038/s41590-020-0761-y ↗
19. 10.1038/s41575-018-0005-x10.1038/s41575-018-0005-x ↗
20. 10.1016/j.ccell.2020.08.00410.1016/j.ccell.2020.08.004 ↗
21. 10.1016/j.canlet.2015.12.02010.1016/j.canlet.2015.12.020 ↗
22. 10.1002/adma.20230579810.1002/adma.202305798 ↗
23. 10.1002/adma.20231045610.1002/adma.202310456 ↗
24. 10.1021/acsnano.2c0630010.1021/acsnano.2c06300 ↗
25. 10.1002/advs.20230515010.1002/advs.202305150 ↗
26. 10.1016/j.nantod.2022.10173310.1016/j.nantod.2022.101733 ↗
27. 10.1002/adfm.20221493710.1002/adfm.202214937 ↗
28. 10.1021/acs.nanolett.4c0000210.1021/acs.nanolett.4c00002 ↗
29. 10.1038/s41467-017-01651-910.1038/s41467-017-01651-9 ↗
30. 10.1016/j.biomaterials.2016.06.03210.1016/j.biomaterials.2016.06.032 ↗
31. 10.1002/adma.20200777810.1002/adma.202007778 ↗
32. 10.1038/nrd313710.1038/nrd3137 ↗
33. 10.1002/adma.20200742610.1002/adma.202007426 ↗
34. 10.1021/acsnano.3c0755510.1021/acsnano.3c07555 ↗
35. 10.1002/anie.20201223710.1002/anie.202012237 ↗
36. 10.1016/j.biomaterials.2020.12007910.1016/j.biomaterials.2020.120079 ↗
37. 10.1002/adma.20200806510.1002/adma.202008065 ↗
38. 10.1002/anie.20191582610.1002/anie.201915826 ↗
39. 10.1016/j.biomaterials.2022.12136910.1016/j.biomaterials.2022.121369 ↗
40. 10.1016/j.biomaterials.2022.12179910.1016/j.biomaterials.2022.121799 ↗
41. 10.1021/acs.nanolett.0c0477810.1021/acs.nanolett.0c04778 ↗
42. 10.1002/adma.20220759310.1002/adma.202207593 ↗
43. 10.1016/j.apsb.2021.11.00510.1016/j.apsb.2021.11.005 ↗
44. 10.1002/advs.20200130810.1002/advs.202001308 ↗
45. 10.1021/acs.nanolett.3c0038310.1021/acs.nanolett.3c00383 ↗
46. 10.1002/adma.20231096410.1002/adma.202310964 ↗
47. 10.1038/s41571-022-00699-x10.1038/s41571-022-00699-x ↗
48. 10.1039/D0CS01121E10.1039/D0CS01121E ↗
49. 10.1126/sciadv.abc945010.1126/sciadv.abc9450 ↗
50. 10.1038/s41551-020-0549-210.1038/s41551-020-0549-2 ↗
51. 10.1002/adma.20231321210.1002/adma.202313212 ↗
52. 10.1002/anie.20231025210.1002/anie.202310252 ↗
53. 10.1038/s41591-022-02129-y10.1038/s41591-022-02129-y ↗
54. 10.1016/j.nantod.2023.10194410.1016/j.nantod.2023.101944 ↗
55. 10.1021/acsami.1c1804910.1021/acsami.1c18049 ↗
56. 10.1038/srep0346810.1038/srep03468 ↗
57. 10.1021/acsnano.1c0913910.1021/acsnano.1c09139 ↗